The icobrain software is FDA and CE cleared for clinical use and is deployed in 100+ hospitals worldwide.

Around 1 in 3 people will suffer from brain diseases, which are typically chronic disorders. A personalized approach is crucial for these patients, as outcome is strongly related to providing the right drug at the right moment to the right person. In addition to having treatment options, reliable monitoring is crucial to make these clinical decisions. In this context, brain imaging plays a central role for both the diagnosis as well as monitoring of brain disorders. However, despite the wealth of information present in brain MRI and CT scans, radiological reporting is still qualitative, subjective and radiologist-dependent. Hence, there is a clear need for a more objective and quantitative analysis of brain scans. icometrix has developed unique solutions to obtain clinically meaningful and quantitative information from these scans. Brain abnormalities and lesions are detected, quantified and compared to previous scans, volume (loss) of specific brain structures is evaluated. These measures can be used by clinicians to make a more accurate diagnosis and to assess disease progression and treatment response.